What is the CMOS study?
The Cannabinoid Medicine Observational Study (CMOS) is Australia’s largest medicinal cannabis observational study. This study aims to collect important real-world evidence on Australian medicinal cannabis prescribing and its outcomes in a 20,000 patient cohort within a 5 year period.
This study will investigate the use of medicinal cannabis treatments in patients presenting with a pain disorder, psychiatric disorder or sleep disorder.
What will the study involve for me?
Your doctor will identify if you are eligible for the study. If you are deemed eligible your doctor will enrol you in the study. You will be contacted monthly to complete the study questionnaires via an email link. The questionnaires take 5-15 minutes to complete.